MY132819A - Pharmaceutical compositions containing n-sulphonylindoline derivatives - Google Patents

Pharmaceutical compositions containing n-sulphonylindoline derivatives

Info

Publication number
MY132819A
MY132819A MYPI97005848A MYPI9705848A MY132819A MY 132819 A MY132819 A MY 132819A MY PI97005848 A MYPI97005848 A MY PI97005848A MY PI9705848 A MYPI9705848 A MY PI9705848A MY 132819 A MY132819 A MY 132819A
Authority
MY
Malaysia
Prior art keywords
amphiphilic
sulphonylindoline
nonionic hydrophilic
derivatives
surfactant
Prior art date
Application number
MYPI97005848A
Other languages
English (en)
Inventor
Fuller Simon John
Jean-Claude Gautier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of MY132819A publication Critical patent/MY132819A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
MYPI97005848A 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonylindoline derivatives MY132819A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
MY132819A true MY132819A (en) 2007-10-31

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97005848A MY132819A (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonylindoline derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (ja)
JP (1) JP2000507618A (ja)
KR (1) KR20000069308A (ja)
CN (1) CN1239887A (ja)
AR (1) AR009651A1 (ja)
AU (1) AU716575B2 (ja)
BR (1) BR9712406A (ja)
CA (1) CA2273990A1 (ja)
CO (1) CO4910129A1 (ja)
DZ (1) DZ2362A1 (ja)
EE (1) EE9900206A (ja)
FR (1) FR2756736B1 (ja)
HU (1) HUP0001386A3 (ja)
ID (1) ID23373A (ja)
IL (1) IL129936A0 (ja)
IS (1) IS5062A (ja)
MY (1) MY132819A (ja)
NO (1) NO992724D0 (ja)
NZ (1) NZ335750A (ja)
RU (1) RU2174394C2 (ja)
SK (1) SK75599A3 (ja)
TR (1) TR199901702T2 (ja)
WO (1) WO1998024430A1 (ja)
YU (1) YU23099A (ja)
ZA (1) ZA9710919B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
CN1239887A (zh) 1999-12-29
NO992724L (no) 1999-06-04
KR20000069308A (ko) 2000-11-25
FR2756736A1 (fr) 1998-06-12
IL129936A0 (en) 2000-02-29
ZA9710919B (en) 1999-06-04
EE9900206A (et) 1999-12-15
TR199901702T2 (en) 1999-09-21
CO4910129A1 (es) 2000-04-24
JP2000507618A (ja) 2000-06-20
SK75599A3 (en) 2000-08-14
NO992724D0 (no) 1999-06-04
AR009651A1 (es) 2000-04-26
WO1998024430A1 (fr) 1998-06-11
DZ2362A1 (fr) 2002-12-28
EP0941090A1 (fr) 1999-09-15
HUP0001386A2 (hu) 2001-04-28
CA2273990A1 (fr) 1998-06-11
AU716575B2 (en) 2000-03-02
BR9712406A (pt) 1999-08-31
HUP0001386A3 (en) 2002-03-28
NZ335750A (en) 2001-06-29
YU23099A (en) 1999-11-22
ID23373A (id) 2000-04-20
RU2174394C2 (ru) 2001-10-10
IS5062A (is) 1999-06-01
AU5326298A (en) 1998-06-29
FR2756736B1 (fr) 1999-03-05

Similar Documents

Publication Publication Date Title
GB2396813A (en) Sunscreen compositions
FI964624A0 (fi) Menetelmä duokarmysiinijohdannaisten stabiloimiseksi
MY113806A (en) Antiparasitic marcfortines and paraherquamides
SG49049A1 (en) 5-(-2-Imidazolinylamino) benzimidazole derivatives their preparation and their use as alpha-2 adrenoceptor agonists
AU1973997A (en) Pentafluorobenzenesulfonamides and analogs
MY132819A (en) Pharmaceutical compositions containing n-sulphonylindoline derivatives
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
CA2129288A1 (en) Phosphonooxymethyl Esters of Taxane Derivatives
EP0693285A3 (en) Pharmaceutical compositions containing a bisphosphonate and an anti-resorptive agent for inhibiting bone loss
AU698744B2 (en) Oil-in-water emulsions
CA2108975A1 (en) Lavatory Cleansing Blocks
IL163865A0 (en) Compositions comprising a non-ionicsurfactant and n-docosanol
MX9606565A (es) Composiciones blanqueadoras.
DE69331007T2 (de) Difluoroavermectin-derivate
AU2881399A (en) N1-modified glycopeptides
BG102716A (en) Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
PT1128820E (pt) Mistura framaceutica compreendendo uma combinacao de profeno e outros compostos activos
AU4435093A (en) Methods and agents for combating cockroaches
ES2054827T3 (es) Uso de alquil fosfatos para la estabilizacion de composiciones tixotropicas.
TH42036A (th) สารผสมทางเภสัชกรรมที่ประกอบด้วยอนุพันธ์ของ n-ซัลโฟนิลอินโดลีน
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
ES2066693A1 (es) Procedimiento de obtencion de una composicion de utilidad en la desfaunacion de un animal.